Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome

Immunodeficiency‐related lymphoproliferative disorders (IR‐LPD) may occur in the setting of immunosuppressive therapy with methotrexate and TNF‐α antagonists. As far as we are aware, this is the first report of an Epstein‐Barr virus‐associated B‐cell lymphoproliferative disorder, secondary to methot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cutaneous pathology 2011-03, Vol.38 (3), p.295-297
Hauptverfasser: Curry, Jonathan L., Prieto, Victor G., Jones, Dan M., Vega, Franscisco, Duvic, Madeleine, Diwan, A. Hafeez
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 297
container_issue 3
container_start_page 295
container_title Journal of cutaneous pathology
container_volume 38
creator Curry, Jonathan L.
Prieto, Victor G.
Jones, Dan M.
Vega, Franscisco
Duvic, Madeleine
Diwan, A. Hafeez
description Immunodeficiency‐related lymphoproliferative disorders (IR‐LPD) may occur in the setting of immunosuppressive therapy with methotrexate and TNF‐α antagonists. As far as we are aware, this is the first report of an Epstein‐Barr virus‐associated B‐cell lymphoproliferative disorder, secondary to methotrexate therapy in a patient with mycosis fungoides/Sézary syndrome. Curry JL, Prieto VG, Jones DM, Vega F, Duvic M, Diwan AH. Transient iatrogenic immunodeficiency‐related B‐cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome.
doi_str_mv 10.1111/j.1600-0560.2009.01459.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1468361614</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1468361614</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4379-1c90c657b6de6911ed6b1ce3a030e572558c8f3726b535a01d5d72a0e4727bf03</originalsourceid><addsrcrecordid>eNqNkcuO0zAUhi0EYkrhFZA3SGySsePaThYsoIIBabho2gGJjeXaJ1N3krjYKdPwGLwFz8GL4dCqbLEs2dL5_nP7EcKU5DSd801OBSEZ4YLkBSFVTuiMV_n-HpqcAvfRhDDCMlGV8gw9inFDCBWl4A_RGa3KsiK8mKCfy6C76KDrsdN98DfQOYNd2-46b6F2JoXMkAVodA8Wv8oMNA1uhna79tvgG1dD0L37Dti66IOFgH2N-zXgeOs6nK7G2wSMBe5cv8btYHx0Ede77sY7C_F88fvXDx0GHIfOBt_CY_Sg1k2EJ8d3iq7fvF7O32aXHy_ezV9eZmbGZJVRUxEjuFwJC6KiFKxYUQNMp6mBy4Lz0pQ1k4VYccY1oZZbWWgCM1nIVU3YFD0_5E1zfNtB7FXr4jie7sDvoqIzUTJBBZ0ltDygJvgYA9RqG1ybmlaUqNERtVHj4tW4eDU6ov46ovZJ-vRYZbdqwf4THi1IwLMjoKPRTZ38MC6euIKVkpepkyl6ceDuXAPDfzeg5tefxl_SZwe9iz3sT3odbpWQTHL15cOFev_56mqx4Ev1lf0B1EK6TQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1468361614</pqid></control><display><type>article</type><title>Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Curry, Jonathan L. ; Prieto, Victor G. ; Jones, Dan M. ; Vega, Franscisco ; Duvic, Madeleine ; Diwan, A. Hafeez</creator><creatorcontrib>Curry, Jonathan L. ; Prieto, Victor G. ; Jones, Dan M. ; Vega, Franscisco ; Duvic, Madeleine ; Diwan, A. Hafeez</creatorcontrib><description>Immunodeficiency‐related lymphoproliferative disorders (IR‐LPD) may occur in the setting of immunosuppressive therapy with methotrexate and TNF‐α antagonists. As far as we are aware, this is the first report of an Epstein‐Barr virus‐associated B‐cell lymphoproliferative disorder, secondary to methotrexate therapy in a patient with mycosis fungoides/Sézary syndrome. Curry JL, Prieto VG, Jones DM, Vega F, Duvic M, Diwan AH. Transient iatrogenic immunodeficiency‐related B‐cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome.</description><identifier>ISSN: 0303-6987</identifier><identifier>EISSN: 1600-0560</identifier><identifier>DOI: 10.1111/j.1600-0560.2009.01459.x</identifier><identifier>PMID: 19889052</identifier><identifier>CODEN: JCUPBN</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Aged ; Azathioprine - therapeutic use ; B-Lymphocytes - pathology ; Biological and medical sciences ; Dermatology ; Epstein-Barr Virus Infections - complications ; Hematologic and hematopoietic diseases ; Humans ; Immunocompromised Host ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Immunosuppressive Agents - therapeutic use ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Lymphoproliferative Disorders - complications ; Lymphoproliferative Disorders - immunology ; Lymphoproliferative Disorders - virology ; Male ; Medical sciences ; Methotrexate - therapeutic use ; Mycosis Fungoides - complications ; Mycosis Fungoides - drug therapy ; Prednisone - therapeutic use ; Sezary Syndrome - complications ; Sezary Syndrome - drug therapy ; Skin Neoplasms - complications ; Skin Neoplasms - drug therapy</subject><ispartof>Journal of cutaneous pathology, 2011-03, Vol.38 (3), p.295-297</ispartof><rights>Copyright © 2009 John Wiley &amp; Sons A/S</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2009 John Wiley &amp; Sons A/S.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4379-1c90c657b6de6911ed6b1ce3a030e572558c8f3726b535a01d5d72a0e4727bf03</citedby><cites>FETCH-LOGICAL-c4379-1c90c657b6de6911ed6b1ce3a030e572558c8f3726b535a01d5d72a0e4727bf03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1600-0560.2009.01459.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1600-0560.2009.01459.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23875868$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19889052$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Curry, Jonathan L.</creatorcontrib><creatorcontrib>Prieto, Victor G.</creatorcontrib><creatorcontrib>Jones, Dan M.</creatorcontrib><creatorcontrib>Vega, Franscisco</creatorcontrib><creatorcontrib>Duvic, Madeleine</creatorcontrib><creatorcontrib>Diwan, A. Hafeez</creatorcontrib><title>Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome</title><title>Journal of cutaneous pathology</title><addtitle>J Cutan Pathol</addtitle><description>Immunodeficiency‐related lymphoproliferative disorders (IR‐LPD) may occur in the setting of immunosuppressive therapy with methotrexate and TNF‐α antagonists. As far as we are aware, this is the first report of an Epstein‐Barr virus‐associated B‐cell lymphoproliferative disorder, secondary to methotrexate therapy in a patient with mycosis fungoides/Sézary syndrome. Curry JL, Prieto VG, Jones DM, Vega F, Duvic M, Diwan AH. Transient iatrogenic immunodeficiency‐related B‐cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome.</description><subject>Aged</subject><subject>Azathioprine - therapeutic use</subject><subject>B-Lymphocytes - pathology</subject><subject>Biological and medical sciences</subject><subject>Dermatology</subject><subject>Epstein-Barr Virus Infections - complications</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Immunocompromised Host</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Lymphoproliferative Disorders - complications</subject><subject>Lymphoproliferative Disorders - immunology</subject><subject>Lymphoproliferative Disorders - virology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methotrexate - therapeutic use</subject><subject>Mycosis Fungoides - complications</subject><subject>Mycosis Fungoides - drug therapy</subject><subject>Prednisone - therapeutic use</subject><subject>Sezary Syndrome - complications</subject><subject>Sezary Syndrome - drug therapy</subject><subject>Skin Neoplasms - complications</subject><subject>Skin Neoplasms - drug therapy</subject><issn>0303-6987</issn><issn>1600-0560</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkcuO0zAUhi0EYkrhFZA3SGySsePaThYsoIIBabho2gGJjeXaJ1N3krjYKdPwGLwFz8GL4dCqbLEs2dL5_nP7EcKU5DSd801OBSEZ4YLkBSFVTuiMV_n-HpqcAvfRhDDCMlGV8gw9inFDCBWl4A_RGa3KsiK8mKCfy6C76KDrsdN98DfQOYNd2-46b6F2JoXMkAVodA8Wv8oMNA1uhna79tvgG1dD0L37Dti66IOFgH2N-zXgeOs6nK7G2wSMBe5cv8btYHx0Ede77sY7C_F88fvXDx0GHIfOBt_CY_Sg1k2EJ8d3iq7fvF7O32aXHy_ezV9eZmbGZJVRUxEjuFwJC6KiFKxYUQNMp6mBy4Lz0pQ1k4VYccY1oZZbWWgCM1nIVU3YFD0_5E1zfNtB7FXr4jie7sDvoqIzUTJBBZ0ltDygJvgYA9RqG1ybmlaUqNERtVHj4tW4eDU6ov46ovZJ-vRYZbdqwf4THi1IwLMjoKPRTZ38MC6euIKVkpepkyl6ceDuXAPDfzeg5tefxl_SZwe9iz3sT3odbpWQTHL15cOFev_56mqx4Ev1lf0B1EK6TQ</recordid><startdate>201103</startdate><enddate>201103</enddate><creator>Curry, Jonathan L.</creator><creator>Prieto, Victor G.</creator><creator>Jones, Dan M.</creator><creator>Vega, Franscisco</creator><creator>Duvic, Madeleine</creator><creator>Diwan, A. Hafeez</creator><general>Blackwell Publishing Ltd</general><general>Wiley-Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>M7N</scope></search><sort><creationdate>201103</creationdate><title>Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome</title><author>Curry, Jonathan L. ; Prieto, Victor G. ; Jones, Dan M. ; Vega, Franscisco ; Duvic, Madeleine ; Diwan, A. Hafeez</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4379-1c90c657b6de6911ed6b1ce3a030e572558c8f3726b535a01d5d72a0e4727bf03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Aged</topic><topic>Azathioprine - therapeutic use</topic><topic>B-Lymphocytes - pathology</topic><topic>Biological and medical sciences</topic><topic>Dermatology</topic><topic>Epstein-Barr Virus Infections - complications</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Immunocompromised Host</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Lymphoproliferative Disorders - complications</topic><topic>Lymphoproliferative Disorders - immunology</topic><topic>Lymphoproliferative Disorders - virology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methotrexate - therapeutic use</topic><topic>Mycosis Fungoides - complications</topic><topic>Mycosis Fungoides - drug therapy</topic><topic>Prednisone - therapeutic use</topic><topic>Sezary Syndrome - complications</topic><topic>Sezary Syndrome - drug therapy</topic><topic>Skin Neoplasms - complications</topic><topic>Skin Neoplasms - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Curry, Jonathan L.</creatorcontrib><creatorcontrib>Prieto, Victor G.</creatorcontrib><creatorcontrib>Jones, Dan M.</creatorcontrib><creatorcontrib>Vega, Franscisco</creatorcontrib><creatorcontrib>Duvic, Madeleine</creatorcontrib><creatorcontrib>Diwan, A. Hafeez</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><jtitle>Journal of cutaneous pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Curry, Jonathan L.</au><au>Prieto, Victor G.</au><au>Jones, Dan M.</au><au>Vega, Franscisco</au><au>Duvic, Madeleine</au><au>Diwan, A. Hafeez</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome</atitle><jtitle>Journal of cutaneous pathology</jtitle><addtitle>J Cutan Pathol</addtitle><date>2011-03</date><risdate>2011</risdate><volume>38</volume><issue>3</issue><spage>295</spage><epage>297</epage><pages>295-297</pages><issn>0303-6987</issn><eissn>1600-0560</eissn><coden>JCUPBN</coden><abstract>Immunodeficiency‐related lymphoproliferative disorders (IR‐LPD) may occur in the setting of immunosuppressive therapy with methotrexate and TNF‐α antagonists. As far as we are aware, this is the first report of an Epstein‐Barr virus‐associated B‐cell lymphoproliferative disorder, secondary to methotrexate therapy in a patient with mycosis fungoides/Sézary syndrome. Curry JL, Prieto VG, Jones DM, Vega F, Duvic M, Diwan AH. Transient iatrogenic immunodeficiency‐related B‐cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>19889052</pmid><doi>10.1111/j.1600-0560.2009.01459.x</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0303-6987
ispartof Journal of cutaneous pathology, 2011-03, Vol.38 (3), p.295-297
issn 0303-6987
1600-0560
language eng
recordid cdi_proquest_miscellaneous_1468361614
source MEDLINE; Wiley Online Library All Journals
subjects Aged
Azathioprine - therapeutic use
B-Lymphocytes - pathology
Biological and medical sciences
Dermatology
Epstein-Barr Virus Infections - complications
Hematologic and hematopoietic diseases
Humans
Immunocompromised Host
Immunodeficiencies
Immunodeficiencies. Immunoglobulinopathies
Immunopathology
Immunosuppressive Agents - therapeutic use
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Lymphoproliferative Disorders - complications
Lymphoproliferative Disorders - immunology
Lymphoproliferative Disorders - virology
Male
Medical sciences
Methotrexate - therapeutic use
Mycosis Fungoides - complications
Mycosis Fungoides - drug therapy
Prednisone - therapeutic use
Sezary Syndrome - complications
Sezary Syndrome - drug therapy
Skin Neoplasms - complications
Skin Neoplasms - drug therapy
title Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T11%3A08%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transient%20iatrogenic%20immunodeficiency-related%20B-cell%20lymphoproliferative%20disorder%20of%20the%20skin%20in%20a%20patient%20with%20mycosis%20fungoides/S%C3%A9zary%20syndrome&rft.jtitle=Journal%20of%20cutaneous%20pathology&rft.au=Curry,%20Jonathan%20L.&rft.date=2011-03&rft.volume=38&rft.issue=3&rft.spage=295&rft.epage=297&rft.pages=295-297&rft.issn=0303-6987&rft.eissn=1600-0560&rft.coden=JCUPBN&rft_id=info:doi/10.1111/j.1600-0560.2009.01459.x&rft_dat=%3Cproquest_cross%3E1468361614%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1468361614&rft_id=info:pmid/19889052&rfr_iscdi=true